OM (OM) Stock Price & Analysis
OM (OM) rose 0.70% to USD 3.59 as of September 8, 2026 at 05:47 UTC, according to Nexqual real-time market data.
OM last closed at USD 3.59; the session ranged USD 3.53–3.65 on volume of 82,236 shares. Market capitalization is —, with a 52-week range of USD 3–16.16 (NMS). Source: Nexqual, September 8, 2026 at 05:47 UTC.
Key Statistics (as of September 8, 2026 at 05:47 UTC)
| Price | USD 3.59 |
|---|---|
| Change | ▲ 0.70% (up) |
| Previous Close | USD 3.59 |
| Open | USD 3.59 |
| Day Range | USD 3.53 – 3.65 |
| 52-Week Range | USD 3 – 16.16 |
| Volume | 82,236 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (OM)
Nexqual's technical model rates OM "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 05:47 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 36.17 (neutral) |
| vs SMA50 | Below (USD 4.41) |
| MACD | -0.25 (negative) |
From OM's Latest SEC 10-K Filing (filed 2026-02-13)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LUNG | Pulmonx Corporation | USD 2.21 | ▼ 3.07% |
| LOB | Live Oak Bancshares, Inc. | USD 39.61 | ▲ 0.25% |
| FTHM | Fathom Holdings Inc. | USD 0.68 | ▲ 4.52% |
| DCBO | Docebo Inc. | USD 24.77 | ▼ 1% |
| PRLD | Prelude Therapeutics Incorporat | USD 5.46 | ▲ 0.55% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:47 UTC. This page is informational and not investment advice.